ACA11 overexpression promoted MM cell proliferation, decreased oxidative stress and reinforced chemotherapy resistance through inhibition of NRF2, a transcriptional regulator of antioxidant response. This evidence concerns the gene SCARNA22 and Miyoshi myopathy.